EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanomedicines for Efficient Diagnosis and Treatment of Pediatric Respiratory Diseases: Prospects and Challenges

Yan Shi, Hui Ma, Han Wenchao, Dan Li

IET Nanobiotechnology · 2026-01 · 2026 (1)

DOI: 10.1049/nbt2/2692282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Nanobiotechnology, online erschienen am 12.08.2026. Verfasst von Yan Shi und 3 weiteren Autor:innen. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric respiratory diseases are a major burden of global disease because they are very common and their pathophysiological mechanisms are complex. Conventional therapies have suboptimal pulmonary deposition, systemic toxicity, and poor patient compliance in children. Nanomedicine based interventions provide targeted pulmonary delivery, promote increased bioavailability, controlled drug release and reduce toxicity. Pulmonary deposition, epithelial uptake and intracellular trafficking are regulated by the physicochemical properties and the functionalization of nanoparticles. Preclinical studies in juvenile animal models show superior pharmacokinetic (PK) properties, preclinical therapeutic efficacy and preliminary clinical studies in pediatric patients show favorable safety and tolerability characteristics. There are still challenges associated with translation, such as immunotoxicity, regulatory issues, and optimizing doses in children. New strategies that combine AI‐assisted design and synthesis of nanoparticles, nanotheranostics, and biodegradable 2D nanomaterials have potential to address these challenges. In this review, recent advances in pediatric nanomedicine for respiratory diseases are discussed with special focus on mechanistic understanding, preclinical evidence, translation to the clinics and future directions of the therapeutic platforms.

Zitieren

APA

Shi, Y., Ma, H., Wenchao, H., & Li, D. (2026). Nanomedicines for Efficient Diagnosis and Treatment of Pediatric Respiratory Diseases: Prospects and Challenges. IET Nanobiotechnology, 2026(1). https://doi.org/10.1049/nbt2/2692282

Vancouver

Shi Y, Ma H, Wenchao H, Li D. Nanomedicines for Efficient Diagnosis and Treatment of Pediatric Respiratory Diseases: Prospects and Challenges. IET Nanobiotechnology. 2026;2026(1). doi:10.1049/nbt2/2692282

BibTeX
@article{Shi2026,
  author = {Shi, Yan and Ma, Hui and Wenchao, Han and Li, Dan},
  title = {Nanomedicines for Efficient Diagnosis and Treatment of Pediatric Respiratory Diseases: Prospects and Challenges},
  journal = {IET Nanobiotechnology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1049/nbt2/2692282}
}
Kostenlos starten →